Screener
ANI Pharmaceuticals ANIP Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: ANI Pharmaceuticals’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001023024-26-000069
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Deferred tax assets, net | 71,495 | 69,072 |
| Intangible assets, net | 449,857 | 479,526 |
| Goodwill | 62,480 | 62,480 |
| Other non-current assets | 11,624 | 13,706 |
| Total Assets | $1,494,112 | $1,440,377 |
| Liabilities and Stockholders’ Equity | ||
| Current Liabilities | ||
| Accounts payable | $73,830 | $62,583 |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is ANI Pharmaceuticals's other non-current assets?
- ANI Pharmaceuticals (ANIP) reported other non-current assets of $11.62M in Q2 2026.
- How has ANI Pharmaceuticals's other non-current assets changed year-over-year?
- ANI Pharmaceuticals's other non-current assets increased by 41.0% year-over-year, from $8.25M to $11.62M.
- What is the long-term trend for ANI Pharmaceuticals's other non-current assets?
- Over 5 years (2020 to 2025), ANI Pharmaceuticals's other non-current assets has grown at a 76.4% compound annual growth rate (CAGR), from $802K to $13.71M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about ANI Pharmaceuticals's other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude